Related Experiment Video

Updated: Jul 2, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Chondrosarcoma and peroxisome proliferator-activated receptor

K Nishida1, T Kunisada, Z N Shen

  • 1Department of Human Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

PPAR Research
|August 30, 2008
PubMed

Insights

PPARgamma ligands show promise in treating chondrosarcoma by inhibiting cancer cell growth and inducing apoptosis. This targeted therapy offers a novel strategy against malignant cartilage tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands induce differentiation and apoptosis in cancer cells.
  • Chondrosarcoma, a malignant cartilage tumor, and the OUMS-27 cell line express PPARgamma.

Purpose of the Study:

  • To investigate the therapeutic potential of PPARgamma ligands in chondrosarcoma.
  • To elucidate the molecular mechanisms underlying PPARgamma ligand-induced apoptosis and proliferation inhibition in chondrosarcoma cells.

Main Methods:

  • Treatment of OUMS-27 cells with PPARgamma ligands, including 15d-PGJ(2).
  • Analysis of cell proliferation, apoptosis markers (Bcl-xL, Bax), and cell cycle regulators (p21).
  • In vivo assessment of Bcl-xL expression in chondrosarcoma tissues.

Main Results:

  • PPARgamma ligands inhibited OUMS-27 cell proliferation in a dose-dependent manner.
  • 15d-PGJ(2) downregulated antiapoptotic Bcl-xL and upregulated proapoptotic Bax, inducing caspase-dependent apoptosis.
  • 15d-PGJ(2) induced p21 protein expression, contributing to cell proliferation inhibition.

Conclusions:

  • Targeted therapy with PPARgamma ligands represents a novel strategy for treating chondrosarcoma.
  • PPARgamma ligands effectively inhibit chondrosarcoma cell proliferation and induce apoptosis through modulation of key molecular pathways.

More Related Videos

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...